Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Factor XIII Concentrate Market Growth 2022-2028

  • LP 4891033
  • 71 Pages
  • March 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Factor XIII Concentrate will have significant change from previous year. According to our (LP Information) latest study, the global Factor XIII Concentrate market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Factor XIII Concentrate market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States Factor XIII Concentrate market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Factor XIII Concentrate market, reaching US$ million by the year 2028. As for the Europe Factor XIII Concentrate landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Factor XIII Concentrate players cover CSL Behring, , , and , etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Factor XIII Concentrate market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6

1000IU

1600IU

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

Hospital

Clinic

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include

CSL Behring

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Factor XIII Concentrate Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Factor XIII Concentrate by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Factor XIII Concentrate by Country/Region, 2017, 2022 & 2028

2.2 Factor XIII Concentrate Segment by Type

2.2.1 1000IU

2.2.2 1600IU

2.3 Factor XIII Concentrate Sales by Type

2.3.1 Global Factor XIII Concentrate Sales Market Share by Type (2017-2022)

2.3.2 Global Factor XIII Concentrate Revenue and Market Share by Type (2017-2022)

2.3.3 Global Factor XIII Concentrate Sale Price by Type (2017-2022)

2.4 Factor XIII Concentrate Segment by Application

2.4.1 Hospital

2.4.2 Clinic

2.5 Factor XIII Concentrate Sales by Application

2.5.1 Global Factor XIII Concentrate Sale Market Share by Application (2017-2022)

2.5.2 Global Factor XIII Concentrate Revenue and Market Share by Application (2017-2022)

2.5.3 Global Factor XIII Concentrate Sale Price by Application (2017-2022)

3 Global Factor XIII Concentrate by Company

3.1 Global Factor XIII Concentrate Breakdown Data by Company

3.1.1 Global Factor XIII Concentrate Annual Sales by Company (2020-2022)

3.1.2 Global Factor XIII Concentrate Sales Market Share by Company (2020-2022)

3.2 Global Factor XIII Concentrate Annual Revenue by Company (2020-2022)

3.2.1 Global Factor XIII Concentrate Revenue by Company (2020-2022)

3.2.2 Global Factor XIII Concentrate Revenue Market Share by Company (2020-2022)

3.3 Global Factor XIII Concentrate Sale Price by Company

3.4 Key Manufacturers Factor XIII Concentrate Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Factor XIII Concentrate Product Location Distribution

3.4.2 Players Factor XIII Concentrate Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Factor XIII Concentrate by Geographic Region

4.1 World Historic Factor XIII Concentrate Market Size by Geographic Region (2017-2022)

4.1.1 Global Factor XIII Concentrate Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Factor XIII Concentrate Annual Revenue by Geographic Region

4.2 World Historic Factor XIII Concentrate Market Size by Country/Region (2017-2022)

4.2.1 Global Factor XIII Concentrate Annual Sales by Country/Region (2017-2022)

4.2.2 Global Factor XIII Concentrate Annual Revenue by Country/Region

4.3 Americas Factor XIII Concentrate Sales Growth

4.4 APAC Factor XIII Concentrate Sales Growth

4.5 Europe Factor XIII Concentrate Sales Growth

4.6 Middle East & Africa Factor XIII Concentrate Sales Growth

5 Americas

5.1 Americas Factor XIII Concentrate Sales by Country

5.1.1 Americas Factor XIII Concentrate Sales by Country (2017-2022)

5.1.2 Americas Factor XIII Concentrate Revenue by Country (2017-2022)

5.2 Americas Factor XIII Concentrate Sales by Type

5.3 Americas Factor XIII Concentrate Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Factor XIII Concentrate Sales by Region

6.1.1 APAC Factor XIII Concentrate Sales by Region (2017-2022)

6.1.2 APAC Factor XIII Concentrate Revenue by Region (2017-2022)

6.2 APAC Factor XIII Concentrate Sales by Type

6.3 APAC Factor XIII Concentrate Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Factor XIII Concentrate by Country

7.1.1 Europe Factor XIII Concentrate Sales by Country (2017-2022)

7.1.2 Europe Factor XIII Concentrate Revenue by Country (2017-2022)

7.2 Europe Factor XIII Concentrate Sales by Type

7.3 Europe Factor XIII Concentrate Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Factor XIII Concentrate by Country

8.1.1 Middle East & Africa Factor XIII Concentrate Sales by Country (2017-2022)

8.1.2 Middle East & Africa Factor XIII Concentrate Revenue by Country (2017-2022)

8.2 Middle East & Africa Factor XIII Concentrate Sales by Type

8.3 Middle East & Africa Factor XIII Concentrate Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Factor XIII Concentrate

10.3 Manufacturing Process Analysis of Factor XIII Concentrate

10.4 Industry Chain Structure of Factor XIII Concentrate

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Factor XIII Concentrate Distributors

11.3 Factor XIII Concentrate Customer

12 World Forecast Review for Factor XIII Concentrate by Geographic Region

12.1 Global Factor XIII Concentrate Market Size Forecast by Region

12.1.1 Global Factor XIII Concentrate Forecast by Region (2023-2028)

12.1.2 Global Factor XIII Concentrate Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Factor XIII Concentrate Forecast by Type

12.7 Global Factor XIII Concentrate Forecast by Application

13 Key Players Analysis

13.1 CSL Behring

13.1.1 CSL Behring Company Information

13.1.2 CSL Behring Factor XIII Concentrate Product Offered

13.1.3 CSL Behring Factor XIII Concentrate Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 CSL Behring Main Business Overview

13.1.5 CSL Behring Latest Developments

14 Research Findings and Conclusion

List of Tables

Table 1. Factor XIII Concentrate Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Factor XIII Concentrate Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of 1000IU

Table 4. Major Players of 1600IU

Table 5. Global Factor XIII Concentrate Sales by Type (2017-2022) & (K Units)

Table 6. Global Factor XIII Concentrate Sales Market Share by Type (2017-2022)

Table 7. Global Factor XIII Concentrate Revenue by Type (2017-2022) & ($ million)

Table 8. Global Factor XIII Concentrate Revenue Market Share by Type (2017-2022)

Table 9. Global Factor XIII Concentrate Sale Price by Type (2017-2022) & (US$/Unit)

Table 10. Global Factor XIII Concentrate Sales by Application (2017-2022) & (K Units)

Table 11. Global Factor XIII Concentrate Sales Market Share by Application (2017-2022)

Table 12. Global Factor XIII Concentrate Revenue by Application (2017-2022)

Table 13. Global Factor XIII Concentrate Revenue Market Share by Application (2017-2022)

Table 14. Global Factor XIII Concentrate Sale Price by Application (2017-2022) & (US$/Unit)

Table 15. Global Factor XIII Concentrate Sales by Company (2020-2022) & (K Units)

Table 16. Global Factor XIII Concentrate Sales Market Share by Company (2020-2022)

Table 17. Global Factor XIII Concentrate Revenue by Company (2020-2022) ($ Millions)

Table 18. Global Factor XIII Concentrate Revenue Market Share by Company (2020-2022)

Table 19. Global Factor XIII Concentrate Sale Price by Company (2020-2022) & (US$/Unit)

Table 20. Key Manufacturers Factor XIII Concentrate Producing Area Distribution and Sales Area

Table 21. Players Factor XIII Concentrate Products Offered

Table 22. Factor XIII Concentrate Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 23. New Products and Potential Entrants

Table 24. Mergers & Acquisitions, Expansion

Table 25. Global Factor XIII Concentrate Sales by Geographic Region (2017-2022) & (K Units)

Table 26. Global Factor XIII Concentrate Sales Market Share Geographic Region (2017-2022)

Table 27. Global Factor XIII Concentrate Revenue by Geographic Region (2017-2022) & ($ millions)

Table 28. Global Factor XIII Concentrate Revenue Market Share by Geographic Region (2017-2022)

Table 29. Global Factor XIII Concentrate Sales by Country/Region (2017-2022) & (K Units)

Table 30. Global Factor XIII Concentrate Sales Market Share by Country/Region (2017-2022)

Table 31. Global Factor XIII Concentrate Revenue by Country/Region (2017-2022) & ($ millions)

Table 32. Global Factor XIII Concentrate Revenue Market Share by Country/Region (2017-2022)

Table 33. Americas Factor XIII Concentrate Sales by Country (2017-2022) & (K Units)

Table 34. Americas Factor XIII Concentrate Sales Market Share by Country (2017-2022)

Table 35. Americas Factor XIII Concentrate Revenue by Country (2017-2022) & ($ Millions)

Table 36. Americas Factor XIII Concentrate Revenue Market Share by Country (2017-2022)

Table 37. Americas Factor XIII Concentrate Sales by Type (2017-2022) & (K Units)

Table 38. Americas Factor XIII Concentrate Sales Market Share by Type (2017-2022)

Table 39. Americas Factor XIII Concentrate Sales by Application (2017-2022) & (K Units)

Table 40. Americas Factor XIII Concentrate Sales Market Share by Application (2017-2022)

Table 41. APAC Factor XIII Concentrate Sales by Region (2017-2022) & (K Units)

Table 42. APAC Factor XIII Concentrate Sales Market Share by Region (2017-2022)

Table 43. APAC Factor XIII Concentrate Revenue by Region (2017-2022) & ($ Millions)

Table 44. APAC Factor XIII Concentrate Revenue Market Share by Region (2017-2022)

Table 45. APAC Factor XIII Concentrate Sales by Type (2017-2022) & (K Units)

Table 46. APAC Factor XIII Concentrate Sales Market Share by Type (2017-2022)

Table 47. APAC Factor XIII Concentrate Sales by Application (2017-2022) & (K Units)

Table 48. APAC Factor XIII Concentrate Sales Market Share by Application (2017-2022)

Table 49. Europe Factor XIII Concentrate Sales by Country (2017-2022) & (K Units)

Table 50. Europe Factor XIII Concentrate Sales Market Share by Country (2017-2022)

Table 51. Europe Factor XIII Concentrate Revenue by Country (2017-2022) & ($ Millions)

Table 52. Europe Factor XIII Concentrate Revenue Market Share by Country (2017-2022)

Table 53. Europe Factor XIII Concentrate Sales by Type (2017-2022) & (K Units)

Table 54. Europe Factor XIII Concentrate Sales Market Share by Type (2017-2022)

Table 55. Europe Factor XIII Concentrate Sales by Application (2017-2022) & (K Units)

Table 56. Europe Factor XIII Concentrate Sales Market Share by Application (2017-2022)

Table 57. Middle East & Africa Factor XIII Concentrate Sales by Country (2017-2022) & (K Units)

Table 58. Middle East & Africa Factor XIII Concentrate Sales Market Share by Country (2017-2022)

Table 59. Middle East & Africa Factor XIII Concentrate Revenue by Country (2017-2022) & ($ Millions)

Table 60. Middle East & Africa Factor XIII Concentrate Revenue Market Share by Country (2017-2022)

Table 61. Middle East & Africa Factor XIII Concentrate Sales by Type (2017-2022) & (K Units)

Table 62. Middle East & Africa Factor XIII Concentrate Sales Market Share by Type (2017-2022)

Table 63. Middle East & Africa Factor XIII Concentrate Sales by Application (2017-2022) & (K Units)

Table 64. Middle East & Africa Factor XIII Concentrate Sales Market Share by Application (2017-2022)

Table 65. Key Market Drivers & Growth Opportunities of Factor XIII Concentrate

Table 66. Key Market Challenges & Risks of Factor XIII Concentrate

Table 67. Key Industry Trends of Factor XIII Concentrate

Table 68. Factor XIII Concentrate Raw Material

Table 69. Key Suppliers of Raw Materials

Table 70. Factor XIII Concentrate Distributors List

Table 71. Factor XIII Concentrate Customer List

Table 72. Global Factor XIII Concentrate Sales Forecast by Region (2023-2028) & (K Units)

Table 73. Global Factor XIII Concentrate Sales Market Forecast by Region

Table 74. Global Factor XIII Concentrate Revenue Forecast by Region (2023-2028) & ($ millions)

Table 75. Global Factor XIII Concentrate Revenue Market Share Forecast by Region (2023-2028)

Table 76. Americas Factor XIII Concentrate Sales Forecast by Country (2023-2028) & (K Units)

Table 77. Americas Factor XIII Concentrate Revenue Forecast by Country (2023-2028) & ($ millions)

Table 78. APAC Factor XIII Concentrate Sales Forecast by Region (2023-2028) & (K Units)

Table 79. APAC Factor XIII Concentrate Revenue Forecast by Region (2023-2028) & ($ millions)

Table 80. Europe Factor XIII Concentrate Sales Forecast by Country (2023-2028) & (K Units)

Table 81. Europe Factor XIII Concentrate Revenue Forecast by Country (2023-2028) & ($ millions)

Table 82. Middle East & Africa Factor XIII Concentrate Sales Forecast by Country (2023-2028) & (K Units)

Table 83. Middle East & Africa Factor XIII Concentrate Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Global Factor XIII Concentrate Sales Forecast by Type (2023-2028) & (K Units)

Table 85. Global Factor XIII Concentrate Sales Market Share Forecast by Type (2023-2028)

Table 86. Global Factor XIII Concentrate Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 87. Global Factor XIII Concentrate Revenue Market Share Forecast by Type (2023-2028)

Table 88. Global Factor XIII Concentrate Sales Forecast by Application (2023-2028) & (K Units)

Table 89. Global Factor XIII Concentrate Sales Market Share Forecast by Application (2023-2028)

Table 90. Global Factor XIII Concentrate Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 91. Global Factor XIII Concentrate Revenue Market Share Forecast by Application (2023-2028)

Table 92. CSL Behring Basic Information, Factor XIII Concentrate Manufacturing Base, Sales Area and Its Competitors

Table 93. CSL Behring Factor XIII Concentrate Product Offered

Table 94. CSL Behring Factor XIII Concentrate Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 95. CSL Behring Main Business

Table 96. CSL Behring Latest Developments

List of Figures

Figure 1. Picture of Factor XIII Concentrate

Figure 2. Factor XIII Concentrate Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Factor XIII Concentrate Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Factor XIII Concentrate Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Factor XIII Concentrate Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of 1000IU

Figure 10. Product Picture of 1600IU

Figure 11. Global Factor XIII Concentrate Sales Market Share by Type in 2021

Figure 12. Global Factor XIII Concentrate Revenue Market Share by Type (2017-2022)

Figure 13. Factor XIII Concentrate Consumed in Hospital

Figure 14. Global Factor XIII Concentrate Market: Hospital (2017-2022) & (K Units)

Figure 15. Factor XIII Concentrate Consumed in Clinic

Figure 16. Global Factor XIII Concentrate Market: Clinic (2017-2022) & (K Units)

Figure 17. Global Factor XIII Concentrate Sales Market Share by Application (2017-2022)

Figure 18. Global Factor XIII Concentrate Revenue Market Share by Application in 2021

Figure 19. Factor XIII Concentrate Revenue Market by Company in 2021 ($ Million)

Figure 20. Global Factor XIII Concentrate Revenue Market Share by Company in 2021

Figure 21. Global Factor XIII Concentrate Sales Market Share by Geographic Region (2017-2022)

Figure 22. Global Factor XIII Concentrate Revenue Market Share by Geographic Region in 2021

Figure 23. Global Factor XIII Concentrate Sales Market Share by Region (2017-2022)

Figure 24. Global Factor XIII Concentrate Revenue Market Share by Country/Region in 2021

Figure 25. Americas Factor XIII Concentrate Sales 2017-2022 (K Units)

Figure 26. Americas Factor XIII Concentrate Revenue 2017-2022 ($ Millions)

Figure 27. APAC Factor XIII Concentrate Sales 2017-2022 (K Units)

Figure 28. APAC Factor XIII Concentrate Revenue 2017-2022 ($ Millions)

Figure 29. Europe Factor XIII Concentrate Sales 2017-2022 (K Units)

Figure 30. Europe Factor XIII Concentrate Revenue 2017-2022 ($ Millions)

Figure 31. Middle East & Africa Factor XIII Concentrate Sales 2017-2022 (K Units)

Figure 32. Middle East & Africa Factor XIII Concentrate Revenue 2017-2022 ($ Millions)

Figure 33. Americas Factor XIII Concentrate Sales Market Share by Country in 2021

Figure 34. Americas Factor XIII Concentrate Revenue Market Share by Country in 2021

Figure 35. United States Factor XIII Concentrate Revenue Growth 2017-2022 ($ Millions)

Figure 36. Canada Factor XIII Concentrate Revenue Growth 2017-2022 ($ Millions)

Figure 37. Mexico Factor XIII Concentrate Revenue Growth 2017-2022 ($ Millions)

Figure 38. Brazil Factor XIII Concentrate Revenue Growth 2017-2022 ($ Millions)

Figure 39. APAC Factor XIII Concentrate Sales Market Share by Region in 2021

Figure 40. APAC Factor XIII Concentrate Revenue Market Share by Regions in 2021

Figure 41. China Factor XIII Concentrate Revenue Growth 2017-2022 ($ Millions)

Figure 42. Japan Factor XIII Concentrate Revenue Growth 2017-2022 ($ Millions)

Figure 43. South Korea Factor XIII Concentrate Revenue Growth 2017-2022 ($ Millions)

Figure 44. Southeast Asia Factor XIII Concentrate Revenue Growth 2017-2022 ($ Millions)

Figure 45. India Factor XIII Concentrate Revenue Growth 2017-2022 ($ Millions)

Figure 46. Australia Factor XIII Concentrate Revenue Growth 2017-2022 ($ Millions)

Figure 47. Europe Factor XIII Concentrate Sales Market Share by Country in 2021

Figure 48. Europe Factor XIII Concentrate Revenue Market Share by Country in 2021

Figure 49. Germany Factor XIII Concentrate Revenue Growth 2017-2022 ($ Millions)

Figure 50. France Factor XIII Concentrate Revenue Growth 2017-2022 ($ Millions)

Figure 51. UK Factor XIII Concentrate Revenue Growth 2017-2022 ($ Millions)

Figure 52. Italy Factor XIII Concentrate Revenue Growth 2017-2022 ($ Millions)

Figure 53. Russia Factor XIII Concentrate Revenue Growth 2017-2022 ($ Millions)

Figure 54. Middle East & Africa Factor XIII Concentrate Sales Market Share by Country in 2021

Figure 55. Middle East & Africa Factor XIII Concentrate Revenue Market Share by Country in 2021

Figure 56. Egypt Factor XIII Concentrate Revenue Growth 2017-2022 ($ Millions)

Figure 57. South Africa Factor XIII Concentrate Revenue Growth 2017-2022 ($ Millions)

Figure 58. Israel Factor XIII Concentrate Revenue Growth 2017-2022 ($ Millions)

Figure 59. Turkey Factor XIII Concentrate Revenue Growth 2017-2022 ($ Millions)

Figure 60. GCC Country Factor XIII Concentrate Revenue Growth 2017-2022 ($ Millions)

Figure 61. Manufacturing Cost Structure Analysis of Factor XIII Concentrate in 2021

Figure 62. Manufacturing Process Analysis of Factor XIII Concentrate

Figure 63. Industry Chain Structure of Factor XIII Concentrate

Figure 64. Channels of Distribution

Figure 65. Distributors Profiles

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390